Narayana Hrudayalaya Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016
January 31, 2017 at 11:56 am
Share
Narayana Hrudayalaya Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, on a standalone basis, the company reported net sales/income from operations of INR 3,929.936 million compared to INR 3,580.548 million a year ago. Earnings from ordinary activities before finance costs and exceptional items was INR 357.765 million compared to INR 265.135 million a year ago. Earnings from ordinary activities before tax was INR 302.146 million compared to INR 221.373 million a year ago. Net profit for the period was INR 193.276 million compared to INR 128.003 million a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.95 compared to INR 0.64 a year ago.
For the nine months, on a standalone basis, the company reported net sales/income from operations of INR 12,117.287 million compared to INR 10,746.858 million a year ago. Earnings from ordinary activities before finance costs and exceptional items was INR 1,190.952 million compared to INR 835.392 million a year ago. Earnings from ordinary activities before tax was INR 1,079.115 million compared to INR 662.144 million a year ago. Net profit for the period was INR 706.625 million compared to INR 440.663 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 3.48 compared to INR 2.21 a year ago.
For quarter, on a consolidated basis, the company reported operating income of INR 4,553 million compared to INR 3,245.521 million a year ago. Consolidated EBITDA stood at INR 565 million as compared to INR 463 million a year ago. PAT after minority interest and share of loss in associates stood at INR 170 million as compared to INR 58 million a year ago. Net sales/income from operations was INR 4,477.376 million compared to INR 3,965.568 million a year ago. Earnings from ordinary activities before finance costs and exceptional items was INR 364.227 million compared to INR 272.163 million a year ago. Earnings from ordinary activities before tax was INR 295.935 million compared to INR 199.337 million a year ago. Net profit for the period was INR 186.656 million compared to INR 109.721 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.84 compared to INR 0.29 a year ago.
For nine months, the company reported operating income of INR 13,946 million compared to INR 11,863 million a year ago. Consolidated EBITDA stood at INR 1,805 million as compared to INR 1,359 million a year ago. PAT after minority interest and share of loss in associates stood at INR 608 million as compared to INR 162 million a year ago. As on December 31st, 2016, the consolidated net debt was INR 1,818 million. Net sales/income from operations was INR 13,694.931 million compared to INR 11,765.661 million a year ago. Earnings from ordinary activities before finance costs and exceptional items was INR 1,217.846 million compared to INR 809.789 million a year ago. Earnings from ordinary activities before tax was INR 1,042.084 million compared to INR 565.572 million a year ago. Net profit for the period was INR 668.506 million compared to INR 341.010 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 3.00 compared to INR 0.81 a year ago.
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
Narayana Hrudayalaya Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016